Prestige Consumer Healthcare
359 hedge funds and large institutions have $4.44B invested in Prestige Consumer Healthcare in 2025 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 107 increasing their positions, 155 reducing their positions, and 22 closing their positions.
118% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 22
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
8% more capital invested
Capital invested by funds: $4.1B → $4.44B (+$346M)
7% more funds holding
Funds holding: 336 → 359 (+23)
1.83% less ownership
Funds ownership: 106.23% → 104.4% (-1.8%)
31% less repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 155
79% less call options, than puts
Call options by funds: $9K | Put options by funds: $43K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$40.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$21.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.4M |
| 4 |
Goldman Sachs
New York
|
+$9.92M |
| 5 |
NPIC
Neumeier Poma Investment Counsel
Carmel,
California
|
+$8.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$42.6M |
| 2 |
LSV Asset Management
Chicago,
Illinois
|
-$23.3M |
| 3 |
BlackRock
New York
|
-$20.4M |
| 4 |
AI
Ariel Investments
Chicago,
Illinois
|
-$19.9M |
| 5 |
ACB
Aristotle Capital Boston
Boston,
Massachusetts
|
-$19M |
PBH Hedge Fund Activity: Q1 2025 in Review
359 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q1 2025, worth a combined $4.44B — up 8.5% from $4.1B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new PBH positions and 22 closed out — a net gain of 26 holders — while 107 added to existing stakes and 155 trimmed.
The largest buyer was Kayne Anderson Rudnick Investment Management, adding an estimated $40.5M. The largest seller was Victory Capital Management, cutting an estimated $42.6M.
- 359 institutional investors held Prestige Consumer Healthcare (PBH) as of Q1 2025, up from 336 in Q4 2024.
- Funds reported $4.44B of Prestige Consumer Healthcare stock for Q1 2025, up 8.5% quarter-over-quarter.
- 48 funds opened new Prestige Consumer Healthcare positions in Q1 2025 and 22 closed out, a net change of +26 holders.
- The largest Prestige Consumer Healthcare buyer in Q1 2025 was Kayne Anderson Rudnick Investment Management, an estimated $40.5M added.
- The largest Prestige Consumer Healthcare seller in Q1 2025 was Victory Capital Management, an estimated $42.6M sold.
Based on aggregated 13F filings for Q1 2025.